Human epiterm growth-factor receptor mutation gene and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
- Publication Date
- 2007-11-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a variety of human epidermal growth factor receptor (EGFR) mutant genes and their applications, and to the application of drug preparation and gene diagnosis, especially in the preparation of non-small cell lung cancer targeted therapy drugs and the treatment of non-small cell lung cancer. Application of growth factor receptor gene detection. Background technique
[0002] Malignant tumors are a serious threat to human health, and their treatment has also become the focus of attention. Due to the lack of specificity, traditional chemotherapy and radiotherapy often bring great toxic and side effects to patients while achieving curative effect. For this reason, the research of anti-tumor targeted drugs has attracted people's attention day by day.
[0003] As we all know, currently the commonly used therapeutic targets for targeted therapy of malignant tumors mainly include: cell receptors, signal transduction and anti-an...